|
GGA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.93274302012969E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23019999964669E-07 |
| Normal-vs-Stage2 |
2.076900E-03 |
| Normal-vs-Stage3 |
2.68562949656825E-13 |
| Normal-vs-Stage4 |
4.12181400122336E-12 |
| Stage1-vs-Stage2 |
7.890800E-01 |
| Stage1-vs-Stage3 |
6.662200E-03 |
| Stage1-vs-Stage4 |
1.842870E-03 |
| Stage2-vs-Stage3 |
4.629800E-02 |
| Stage2-vs-Stage4 |
1.176070E-02 |
| Stage3-vs-Stage4 |
3.983000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.60991228628882E-12 |
| Normal-vs-AfricanAmerican |
8.301000E-03 |
| Normal-vs-Asian |
8.596000E-01 |
| Caucasian-vs-AfricanAmerican |
5.916600E-01 |
| Caucasian-vs-Asian |
7.843800E-02 |
| AfricanAmerican-vs-Asian |
3.700800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.41788836017076E-14 |
| Normal-vs-Female |
1.69292999999682E-05 |
| Male-vs-Female |
1.315990E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.24680000049382E-07 |
| Normal-vs-Age(41-60Yrs) |
1.43170000299619E-08 |
| Normal-vs-Age(61-80Yrs) |
2.99960056793225E-11 |
| Normal-vs-Age(81-100Yrs) |
2.572300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.336200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.769200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.846000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.612000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.732000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.186600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.640800E-01 |
| Normal-vs-Grade 2 |
1.7724999246127E-10 |
| Normal-vs-Grade 3 |
2.47470000047656E-09 |
| Normal-vs-Grade 4 |
9.01512198225873E-12 |
| Grade 1-vs-Grade 2 |
2.646200E-01 |
| Grade 1-vs-Grade 3 |
2.740000E-01 |
| Grade 1-vs-Grade 4 |
1.243370E-01 |
| Grade 2-vs-Grade 3 |
9.054800E-01 |
| Grade 2-vs-Grade 4 |
3.051900E-02 |
| Grade 3-vs-Grade 4 |
3.935600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.44339999847065E-08 |
| Normal-vs-ccB subtype |
3.48430000407518E-08 |
| ccA subtype-vs-ccB subtype |
3.929600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.64269999719724E-08 |
| Normal-vs-N1 |
5.564300E-02 |
| N0-vs-N1 |
8.972400E-01 |
|
|
